Applied DNA Sciences Inc
APDN5.620USD
0.000
收盘 12/24, 13:00（美东）报价延迟15分钟
5.07M总市值
亏损市盈率 TTM
关于 Applied DNA Sciences Inc 公司
Applied DNA Sciences, Inc. is a biotechnology company. The Company is engaged in developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The Company operates through three segments: Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. Therapeutic DNA Production Services segment operations consist of the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and, the development and sale of a proprietary RNAP for use in the production of messenger RNA (mRNA) therapeutics. MDx Testing Service segment operations consist of performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. DNA Tagging and Security Products and Services segment operations consist of the manufacture and detection of DNA for industrial supply chains and security services.
Applied DNA Sciences Inc简介
公司代码APDN
公司名称Applied DNA Sciences Inc
上市日期Aug 24, 2001
CEOShorrock (Clay)
员工数量46
证券类型Ordinary Share
年结日Aug 24
公司地址50 Health Sciences Drive
城市STONY BROOK
上市交易所NASDAQ Capital Market Consolidated
国家United States of America
邮编11790
电话16312408800
网址https://adnas.com/
公司代码APDN
上市日期Aug 24, 2001
CEOShorrock (Clay)
Applied DNA Sciences Inc公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Joshua (Josh) Kruger
Mr. Joshua (Josh) Kruger
Chairman of the Board
Chairman of the Board
75.30K
--
Mr. Clay Shorrock, J.D.
Mr. Clay Shorrock, J.D.
Chief Executive Officer
Chief Executive Officer
18.70K
+467275.00%
Ms. Beth M. Jantzen
Ms. Beth M. Jantzen
Chief Financial Officer
Chief Financial Officer
18.69K
+623033.33%
Mr. Robert B. (Bob) Catell
Mr. Robert B. (Bob) Catell
Independent Director
Independent Director
1.00
--
Mr. Joseph D. Ceccoli
Mr. Joseph D. Ceccoli
Independent Director
Independent Director
1.00
--
Ms. Judith Murrah
Ms. Judith Murrah
Director
Director
1.00
-66.67%
Dr. Yacov A. Shamash, Ph.D.
Dr. Yacov A. Shamash, Ph.D.
Independent Director
Independent Director
1.00
--
Ms. Elizabeth M. Schmalz Shaheen
Ms. Elizabeth M. Schmalz Shaheen
Independent Director
Independent Director
--
--
Mr. Sanjay M. Hurry
Mr. Sanjay M. Hurry
Executive Director - Investor Relations and Corporate Communications
Executive Director - Investor Relations and Corporate Communications
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Joshua (Josh) Kruger
Mr. Joshua (Josh) Kruger
Chairman of the Board
Chairman of the Board
75.30K
--
Mr. Clay Shorrock, J.D.
Mr. Clay Shorrock, J.D.
Chief Executive Officer
Chief Executive Officer
18.70K
+467275.00%
Ms. Beth M. Jantzen
Ms. Beth M. Jantzen
Chief Financial Officer
Chief Financial Officer
18.69K
+623033.33%
Mr. Robert B. (Bob) Catell
Mr. Robert B. (Bob) Catell
Independent Director
Independent Director
1.00
--
Mr. Joseph D. Ceccoli
Mr. Joseph D. Ceccoli
Independent Director
Independent Director
1.00
--
Ms. Judith Murrah
Ms. Judith Murrah
Director
Director
1.00
-66.67%
收入明细
单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
Product and authentication services - Large scale DNA production
161.00K
52.89%
Product and authentication services - Supply chain
91.32K
30.00%
Research and development services
52.07K
17.11%
由于公司未披露，未能获取相关数据
业务
地区
业务USD
名称
营收
占比
Product and authentication services - Large scale DNA production
161.00K
52.89%
Product and authentication services - Supply chain
91.32K
30.00%
Research and development services
52.07K
17.11%
股东统计
更新时间: 12月24日 周三
更新时间: 12月24日 周三
持股股东
股东类型
持股股东
持股股东
占比
Kruger (Joshua)
1.72%
FNY Investment Advisers LLC
0.69%
Schmalz (Elizabeth M.)
0.52%
Ceccoli (Joseph D)
0.52%
Shamash (Yacov A)
0.52%
其他
96.04%
持股股东
持股股东
占比
Kruger (Joshua)
1.72%
FNY Investment Advisers LLC
0.69%
Schmalz (Elizabeth M.)
0.52%
Ceccoli (Joseph D)
0.52%
Shamash (Yacov A)
0.52%
其他
96.04%
股东类型
持股股东
占比
Individual Investor
2.59%
Investment Advisor/Hedge Fund
0.80%
Bank and Trust
0.10%
Investment Advisor
0.07%
Hedge Fund
0.02%
其他
96.42%
机构持股
更新时间: 12月8日 周一
更新时间: 12月8日 周一
报告期
机构数
持股数
持股占比
持股变动
2025Q4
62
12.01K
1.97%
+3.60K
2025Q3
64
19.08K
7.51%
-74.50K
2025Q2
62
93.59K
3.11%
+68.02K
2025Q1
58
35.01K
5.59%
+11.41K
2024Q4
55
23.97K
30.73%
+2.04K
2024Q3
51
1.16K
3.54%
+725.00
2024Q2
53
1.30K
7.24%
+394.00
2024Q1
46
185.00
329.31%
-6.00
2023Q4
44
114.00
24.92%
-67.00
2023Q3
47
182.00
32.27%
+23.00
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Jantzen (Beth M)
3.00
0%
--
--
Apr 03, 2025
Shorrock (Clay)
4.00
0%
--
--
Apr 03, 2025
UBS Switzerland AG
493.00
0.04%
+493.00
--
Jun 30, 2025
查看更多
持股ETF
机构名称
占比
暂无数据
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
May 29, 2025
Merger
15→1
Mar 12, 2025
Merger
50→1
Mar 12, 2025
Merger
50→1
Mar 12, 2025
Merger
50→1
Mar 12, 2025
Merger
50→1
Apr 22, 2024
Merger
20→1
公告日期
类型
比率
May 29, 2025
Merger
15→1
Mar 12, 2025
Merger
50→1
Mar 12, 2025
Merger
50→1
Mar 12, 2025
Merger
50→1
Mar 12, 2025
Merger
50→1
Apr 22, 2024
Merger
20→1
Apr 22, 2024
Merger
20→1
Apr 22, 2024
Merger
20→1
Apr 22, 2024
Merger
20→1
常见问题
Applied DNA Sciences Inc的前五大股东是谁？
Applied DNA Sciences Inc 的前五大股东如下：
Jantzen (Beth M)持有股份：3.00，占总股份比例：0.00%。
Shorrock (Clay)持有股份：4.00，占总股份比例：0.00%。
UBS Switzerland AG持有股份：493.00，占总股份比例：0.04%。
Jantzen (Beth M)持有股份：3.00，占总股份比例：0.00%。
Shorrock (Clay)持有股份：4.00，占总股份比例：0.00%。
UBS Switzerland AG持有股份：493.00，占总股份比例：0.04%。
Applied DNA Sciences Inc的前三大股东类型是什么？
Applied DNA Sciences Inc 的前三大股东类型分别是：
Kruger (Joshua)
FNY Investment Advisers LLC
Schmalz (Elizabeth M.)
Kruger (Joshua)
FNY Investment Advisers LLC
Schmalz (Elizabeth M.)
有多少机构持有Applied DNA Sciences Inc(APDN)的股份？
截至2025Q4，共有62家机构持有Applied DNA Sciences Inc的股份，合计持有的股份价值约为12.01K，占公司总股份的1.97%。与2025Q3相比，机构持股有所增加，增幅为-5.54%。
哪个业务部门对Applied DNA Sciences Inc的收入贡献最大？
在FY2025Q3，Product and authentication services - Large scale DNA production业务部门对Applied DNA Sciences Inc的收入贡献最大，创收161.00K，占总收入的52.89%。
